Effect of Miricorilant, a Selective Glucocorticoid Receptor Modulator, on Olanzapine-Associated Weight Gain in Healthy Subjects: A Proof-of-Concept Study.

J Clin Psychopharmacol · 2021 · PMC8575171 · PMID 34369902

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

close to achieving significanceP = 0.057so close (0.05 < p ≤ 0.1)

The estimated difference between the miricorilant group and the placebo group was statistically significant on day 8 ( P < 0.001) and close to achieving significance on day 15 ( P = 0.057).

also in 15 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.